New book by Larry Connors Click here Improve your trading - See how
The MM&M Awards, sponsored by Medical Marketing & Media magazine, recognize exceptional creativity and marketing effectiveness in the healthcare sector. Winners are determined by an independent panel of experts drawn from all of the marketing specialties ranging from media buying/planning to direct marketing and advertising. This year's event garnered over 700 entries from more than 150 competing companies.
GSW Worldwide, a leading global healthcare advertising agency, swept the category of Best Overall Advertising Campaign for Professional Press. The agency was awarded a Gold for their 'Tilt a Jumbler' campaign for MGI Pharma's Post-Operative Nausea and Vomiting (PONV). GSW also nabbed the Silver award in the same category for Astellas Pharma US 'Itchcraft' campaign for Protopic, an ointment used to treat moderate to severe eczema.
Ignite Health, a leading healthcare interactive agency, was honored with a Gold award in the Best Interactive Initiative for Consumer category for Advanced Medical Optics's (AMO) Reality LASIK (iLasik.com), a video-based consumer website that provides patient education and professional insights on the Lasik procedure and new technological advancements in vision correction. The site was created to reach Generation Y through video, social networking and viral marketing.
Palio, a leading full-service healthcare advertising and communications agency, received a Gold award in the Best Corporate Advertisement/Campaign category for 'Helping Patients Stay on Therapy,' a print campaign they developed for Adheris, a leading compliance and patient education company.
"We are thrilled to be recognized by MM&M for the creative solutions that inVentiv is providing for our clients," said Bill O'Donnell, president and COO of inVentiv Communications. "inVentiv's companies continue to be industry leaders in all aspects of the healthcare communications business. We are extremely honored that GSW Worldwide, Ignite Health and Palio are among the prestigious winners of the MM&M Awards."
About inVentiv Health
inVentiv Health, Inc. (Nasdaq:VTIV) is an insights-driven global healthcare leader that provides dynamic solutions to deliver customer and patient success. inVentiv delivers its customized clinical, sales, marketing and communications solutions through its four core business segments: inVentiv Clinical, inVentiv Communications, inVentiv Commercial, and inVentiv Patient Outcomes. inVentiv Health's client roster is comprised of more than 350 leading pharmaceutical, biotech, life sciences and healthcare payor companies, including all top 20 global pharmaceutical manufacturers. For more information, visit www.inventivhealth.com.
The inVentiv Health, Inc. logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=4942
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve known and unknown risks that may cause inVentiv Health's performance to differ materially. Such risks include, without limitation: changes in trends in the pharmaceutical industry or in pharmaceutical outsourcing; our ability to compete successfully with other services in the market; our ability to maintain large client contracts or to enter into new contracts; and, our ability to operate successfully in new lines of business. Readers of this press release are referred to documents filed from time to time by inVentiv Health, Inc. with the Securities and Exchange Commission for further discussion of these and other factors.
This news release was distributed by GlobeNewswire, www.globenewswire.com
SOURCE: inVentiv Health, Inc.
inVentiv Health, Inc. Investors/Corporate: David Bassin, CFO (732) 537-4804 investor@inventivhealth.com Media: Marcia Frederick (614) 543-6281 mfrederick@inventivhealth.com
More News:
Market Updates |
Stock Alerts |
All Trading News |
Stock Index
About TradingMarkets | Contact | Advertise | Careers | Link to Us | Site Map | Help | Terms & Conditions | Privacy Policy | Return Policy | Testimonials | Feedback
The Connors Group, Inc. ("Company") is not an investment advisory service, nor a registered investment advisor or broker-dealer and does not purport to tell or suggest which securities or currencies customers should buy or sell for themselves. The analysts and employees or affiliates of Company may hold positions in the stocks, currencies or industries discussed here. You understand and acknowledge that there is a very high degree of risk involved in trading securities and/or currencies. The Company, the authors, the publisher, and all affiliates of Company assume no responsibility or liability for your trading and investment results. Factual statements on the Company's website, or in its publications, are made as of the date stated and are subject to change without notice.
It should not be assumed that the methods, techniques, or indicators presented in these products will be profitable or that they will not result in losses. Past results of any individual trader or trading system published by Company are not indicative of future returns by that trader or system, and are not indicative of future returns which be realized by you. In addition, the indicators, strategies, columns, articles and all other features of Company's products (collectively, the "Information") are provided for informational and educational purposes only and should not be construed as investment advice. Examples presented on Company's website are for educational purposes only. Such set-ups are not solicitations of any order to buy or sell. Accordingly, you should not rely solely on the Information in making any investment. Rather, you should use the Information only as a starting point for doing additional independent research in order to allow you to form your own opinion regarding investments. You should always check with your licensed financial advisor and tax advisor to determine the suitability of any investment.
HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN INHERENT LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING AND MAY NOT BE IMPACTED BY BROKERAGE AND OTHER SLIPPAGE FEES. ALSO, SINCE THE TRADES HAVE NOT ACTUALLY BEEN EXECUTED, THE RESULTS MAY HAVE UNDER- OR OVER-COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY. SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFITS OR LOSSES SIMILAR TO THOSE SHOWN.
The Connors Group, Inc.
10 Exchange Place, Suite 1800
Jersey City, NJ 07302
© Copyright 2009 The Connors Group, Inc.
